Bnp Paribas Asset Management Holding S.A. Akero Therapeutics, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 492 shares of AKRO stock, worth $24,826. This represents 0.0% of its overall portfolio holdings.
Number of Shares
492Holding current value
$24,826% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
277Shares Held
85.3MCall Options Held
1.02MPut Options Held
823K-
Rtw Investments, LP New York, NY7.42MShares$374 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$357 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$300 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$282 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$264 Million7.15% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.34B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...